Press

Gnosis by Lesaffre welcomes the opportunity to engage with the media ​about the impact of our clinically proven MenaQ7® can have on the state of ​​global health.

Press inquiries can be directed to Kate Quackenbush, Communications Director:

K.QUACKENBUSH@gnosis.lesaffre.com